Home » Topics » BioWorld Science

BioWorld Science
RSS

Sorrento's STI-9167 neutralizes Omicron and Omicron (+R346k) variants of SARS-CoV-2

Jan. 24, 2022

Anti-ANXA1 antibody MDX-124 shows promise in preclinical models of pancreatic cancer

Jan. 24, 2022

HS6ST2 predicts survival in PDAC

Jan. 24, 2022

IM-1761065, a novel biguanide with promising activity in models of glioblastoma

Jan. 24, 2022

Oasmia advances its next-generation XR-18 drug delivery technology

Jan. 24, 2022

Engineered virus-like particles for in vivo delivery of gene editing proteins

Jan. 24, 2022

New approach integrates CAR-T cell immunotherapy with local activation of small-molecule prodrugs

Jan. 24, 2022

Inventisbio Shanghai discloses GTPase KRAS mutant inhibitors

Jan. 24, 2022

Shanghai Institute of Materia Medica identifies new S1PR1 agonists

Jan. 24, 2022

Immunophage Biomedical presents new CCR8 antagonists

Jan. 24, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026